BEAM vs BROS · rev $63.5M vs P/E 105, rev $1.28B
Beam Therapeutics Inc (BEAM) versus Dutch Bros Inc (BROS) — a side-by-side from cached financials, not a winner call.
Beam Therapeutics Inc (BEAM) is a biotechnology company listed on US.
Dutch Bros Inc (BROS) is a restaurants company listed on NYSE.
Latest reported BEAM revenue for 2024-12-31 was $63.5M. Net income was -$376.7M. Revenue was down 83.2% from 2023-12-31 to 2024-12-31. BEAM currently screens at market cap $2.01B.
Latest reported BROS revenue for 2024-12-31 was $1.28B. Net income was $66.5M. Revenue was up 32.6% from 2023-12-31 to 2024-12-31. BROS currently screens at market cap $11.74B and trailing P/E 105.0.
BEAM currently screens at market cap $2.01B. BROS currently screens at market cap $11.74B and trailing P/E 105.0.
Not investment advice. Open the BEAM and BROS stock pages for the full models.
Not investment advice.